Medulloblastoma subgroups stratification using transcriptome and RNA modification landscape

CBTN cohort is comprehensive in encompassing various subgroups of medulloblastoma. Access to patient samples will enable us in efficiently sequencing the native RNA. Clinical information associated with samples that is available with CBTN samples is important in building prototype to successfully delineate subgroups using novel sequencing technology rapidly. Additionally, the genomic and epigenomic datasets previously generated by colleagues in the field with the samples from CBTN will aid in basic research from the findings of our study. Research findings from this project will be presented in conferences and published as peer reviewed papers. Data will be deposited to CBTN website appropriately.